Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00727532
Recruitment Status : Terminated (Low Accrual)
First Posted : August 4, 2008
Last Update Posted : July 18, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Northwestern University

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2011
  Estimated Study Completion Date : June 2015

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 April 7, 2016
May 11, 2016
2 April 17, 2017
May 26, 2017
3 May 3, 2018
June 6, 2018
4 October 22, 2018
November 20, 2018